Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 7Terminated 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Dermatologic 1

Conditions

Lymphoma 3Mycosis Fungoides 2Sezary Syndrome 1Parapsoriasis 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Mycophenolic Acid 7fludarabine phosphate 6Rituximab 6Radiotherapy 6Cyclophosphamide 6Antilymphocyte Serum 6Peripheral Blood Stem Cell Transplantation 5Filgrastim 5Cyclosporine 5Whole-Body Irradiation 4Tacrolimus 4Methotrexate 4Flow Cytometry 4Etoposide 4Cord Blood Stem Cell Transplantation 4Busulfan 4tanespimycin 3romidepsin 3Melphalan 3Magnetic Resonance Spectroscopy 3Lenalidomide 3Gemcitabine 3Bortezomib 3plerixafor 2nelarabine 2mogamulizumab 2cobomarsen 2carfilzomib 2belinostat 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Mycosis Fungoides × Bexarotene × Clear all
NCT00056056 2018-07-09

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
93 enrolled
Lymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome

NCT00322296 2013-04-16

Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis

Fox Chase Cancer Center

Phase 2 Terminated
8 enrolled
DermatologicLymphoid

Mycosis Fungoides, Parapsoriasis, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡